“How much does it hurt, on a scale of 1-10?” Easily the most frustratingly vague of medical questions due to the huge difference in pain thresholds and perceptions. I don’t know about you, but I’m saving my 10 for childbirth. Nonetheless, when the answer falls beneath an epidural-requiring 10, many of us reach for simple
Read More
Clinical stage pharmaceutical company Pharmaxis (PXS: ASX) is full steam ahead with their Phase 2 clinical trial for flagship drug, PXS-5505. The Company has launched new clinical trial sites in Taiwan in a planned expansion to boost patient recruitment. Designed for use in the treatment of myelofibrosis, a rare blood cancer with a poor prognosis,
Read More
4,440 US hospitals and health systems will soon have access to Avita Medical’s (ASX: AVH) proprietary RECELL System thanks to a purchasing agreement signed with Premier, a leading healthcare improvement company in the US. Premier’s mission is to enable optimal patient care at reasonable cost within their alliance of 4,400 US hospitals and 225,000 other
Read More
Things are well and truly on track for clinical stage pharmaceutical company Pharmaxis (ASX: PXS), a sentiment confirmed by CEO Gary Phillips in his shareholder address in their recent quarterly results. The Company has made significant progress in three clinical trial programs, with plenty on the horizon for their preclinical pipeline too. Lead asset PXS-5505
Read More
Our minds can be our greatest asset and our biggest enemy. The same humans that built aeroplanes, rockets and the internet are just as prone to ailments like depression, anxiety and functional cognitive decline. Unfortunately when it comes to cognition, doing the odd sudoku probably won’t cut it if you’re hoping to maintain your current
Read More
